For USA & Canada visitors: therogenx.com is an international website that has not been evaluated by the United States Food and Drug Administration. Statements and/or claims on this site are not intended to prevent, diagnose, treat or cure any ailments or diseases. Information and product/packaging on this site is for informational purposes only and is not intended as a substitution for advice from a physician or health-care professional. Information shown on this site may describe clearances in countries other than the USA and Canada, hence it may include indications and information that are outside the scope of FDA-cleared labeling.

Do you understand and want to proceed?
Yes, Please Proceed
About
Medical Products
Foot & Ankle
Sports Medicine
Trauma
Biologics
Research
Research & Global Distribution
News
Contact

International | Research & Global Distribution

International | Research & Global Distribution

TherogenX supports international partners and research institutions through the supply of advanced biologic materials intended for research, laboratory, and investigational use. As global markets continue to expand in regenerative medicine and biologic sciences, TherogenX is positioned to provide high-quality, structurally derived tissue-based products for scientific evaluation and product development.

Our research-focused offerings are centered around extracellular matrix (ECM) materials and biologic components that are widely studied for their structural, biochemical, and signaling characteristics. These materials may be utilized by qualified organizations for laboratory research, preclinical evaluation, and product innovation initiatives.

TherogenX works with international distributors, research organizations, and commercial partners seeking reliable access to biologic materials that meet strict processing, quality, and consistency standards. Through our vertically integrated platform, we are able to support scalable supply and repeatable product specifications for research and development purposes.

In addition to structural ECM-based materials, TherogenX continues to monitor and evaluate emerging scientific areas of interest, including extracellular vesicles such as exosomes and evolving cell-based technologies. These areas represent a growing focus within the global regenerative medicine landscape and may serve as future areas of research collaboration and product development.

All research products are intended for investigational and laboratory use only and are not intended for clinical application in regions where regulatory approvals have not been established. International partners are responsible for ensuring compliance with local regulatory requirements within their respective markets.

For international partnerships, research collaborations, or distribution inquiries, please contact TherogenX to explore available opportunities.

Pipeline

About

News

Research

About

Research

News